Treatment patterns of castration-resistant prostate cancer: A retrospective claims database analysis

被引：0
|
作者：
Burton, Tanya
Teitelbaum, April H.
Bui, Cat N.
Spalding, James Robert
机构：
[1] OptumInsight, Waltham, MA USA
[2] OptumInsight, San Diego, CA USA
[3] Astellas Pharma US Inc, Northbrook, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 34期
关键词：
D O I：
10.1200/jco.2012.30.34_suppl.198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
198
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Abiraterone for castration-resistant prostate cancer: adherence, survival and hospitalizationAnalysis of a medical claims database
    Badereddin Mohamad Al-Ali
    Gero Kramer
    Stephan Madersbacher
    Ingrid Berger
    Wiener klinische Wochenschrift, 2017, 129 : 380 - 384
  • [2] Burden of illness of chemotherapy in castration-resistant prostate cancer patients in Japan: a retrospective database analysis
    Mahlich, Joerg
    Tsubota, Akiko
    Imanaka, Keiichiro
    Enjo, Kentaro
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1855 - 1860
  • [3] A retrospective analysis of treatment patterns in metastatic castration-resistant prostate cancer patients treated with radium-223.
    Sartor, A. Oliver
    Appukkuttan, Sreevalsa
    Aubert, Ronald E.
    Weiss, Jeffrey
    Wang, Joy
    Simmons, Stacey
    Tsao, Che-Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [4] Treatment patterns by oncologists and urologists for castration-resistant prostate cancer (CRPC)
    Alemayehu, B.
    Nitz, N. M. Engel-
    Nathan, F. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Treatment patterns and characteristics of European patients with castration-resistant prostate cancer
    Cora N Sternberg
    Edwina S Baskin-Bey
    Mark Watson
    Andrew Worsfold
    Alex Rider
    Bertrand Tombal
    BMC Urology, 13
  • [6] Validation of a complex algorithm for the diagnosis of metastatic castration-resistant prostate cancer within a claims database
    Thurin, Nicolas
    Rouyer, Magali
    Gross-Goupil, Marine
    Soulie, Michel
    Le Moulec, Sylvestre
    De Beaucoudrey, Ludovic
    Lamarque, Stephanie
    Bignon, Emmanuelle
    Jove, Jeremy
    Droz-Perroteau, Cecile
    Moore, Nicholas
    Blin, Patrick
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 165 - 165
  • [7] Treatment patterns in men with castration-resistant prostate cancer receiving docetaxel
    Davis, Keith L.
    Gutierrez, Benjamin
    Zyczynski, Teresa Maria
    Kaye, James A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Treatment patterns and characteristics of European patients with castration-resistant prostate cancer
    Sternberg, Cora N.
    Baskin-Bey, Edwina S.
    Watson, Mark
    Worsfold, Andrew
    Rider, Alex
    Tombal, Bertrand
    BMC UROLOGY, 2013, 13
  • [9] Cabazitaxel for the treatment of castration-resistant prostate cancer
    Agarwal, Neeraj
    Sonpavde, Guru
    Sartor, Oliver
    FUTURE ONCOLOGY, 2011, 7 (01) : 15 - 24
  • [10] Castration-resistant Prostate cancer: Treatment is differentiated
    Wolff, Johannes M.
    AKTUELLE UROLOGIE, 2011, 42 (02)
12345